Healthcare entity
Every one of those 1 sits in a single category, market-trends. Evolysse is most often covered alongside AbbVie, which appears in 1 of these 1 story. Each story carries 4 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Evolysse is most often covered alongside AbbVie, which appears in 1 of these 1 story. Each story carries 4 original sources on average, compared with 2.8 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention Evolysse, all published on March 5, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Evolysse. Shared-story counts are live from our verified record — not editorial picks.
Earnings Release
Company reports Q4 beat and issues bullish 2026 revenue guidance.
Evolysse Launch
Anticipated commercial rollout of the Evolysse dermal filler portfolio in the U.S.
Q4 Fiscal Close
Evolus concludes its strongest fiscal year to date with record Jeuveau sales.
Evolus reported record Q4 2025 financial results, triggering a significant stock rally following a revenue beat and robust 2026 guidance. The company's performance underscores the resilience of the medical aesthetics market and the growing adoption of its flagship neurotoxin, Jeuveau.
Source: finance.yahoo.com · finance.yahoo.com
Evolysse is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
